Group 1 - The total salary scale of CFOs in A-share listed companies for 2024 reaches 4.27 billion yuan, with an average salary of approximately 675,800 yuan in the environmental equipment II industry [1] - The highest salary among CFOs is 1.55 million yuan for Qiu Shucai from Longjing Environmental Protection, while the lowest is 461,800 yuan for Zhou Xianyun from Wanyi Technology [1] - The average age of CFOs is 46.9 years, with the oldest being 54 years old and the youngest at 37 years old [1] Group 2 - There is a reverse correlation between salary and education level among CFOs, with average salaries of 488,700 yuan for PhDs, 710,800 yuan for Masters, 758,100 yuan for Bachelors, and 452,800 yuan for those with associate degrees [1] - Some CFOs' salaries are not aligned with company performance, indicating a disconnect between compensation and company profitability [1] - Two CFOs received warnings or public notifications for violations in 2024-2025 [1] Group 3 - Wang Qingbo from Yingfeng Environment received two warnings but has a salary of 1.1998 million yuan for 2024, an increase of 398,800 yuan or 50% from 2023 [2] - Wang Jin from Bixing Wulian received one warning, with a salary of 574,100 yuan, due to failure to update semi-annual performance forecasts and timely disclose significant contracts [2]

Core Insights - The report highlights the significant increase in CFO salaries within A-share listed companies, with a total compensation of 4.27 billion yuan and an average salary of 814,800 yuan for 2024 [1][2] - Despite a 74.42% decline in stock price, CFO Fan Yi of Huaheng Biological saw a salary increase of 48.18%, raising concerns about the disconnect between executive compensation and company performance [1][2] Summary by Sections CFO Salary Overview - The total salary for CFOs in A-share listed companies reached 4.27 billion yuan in 2024, with an average salary of 814,800 yuan [1] - Huaheng Biological's CFO, Fan Yi, received a salary of 1.62 million yuan, an increase of 526,700 yuan or 48.18% from the previous year [1][3] Company Performance - Huaheng Biological reported a total revenue increase of 12.37% to 2.178 billion yuan, but its net profit dropped by 57.80% to 190 million yuan [1] - The company's stock price fell by 74.42%, indicating a poor market performance despite revenue growth [1][2] Executive Background - Fan Yi has been with Huaheng Biological since January 2016, holding multiple roles including CFO and board secretary, and has prior experience in finance and mergers at BASF Greater China [2]